当前位置:首页 - 行情中心 - 百花医药(600721) - 财务分析

百花医药

(600721)

  

流通市值:30.49亿  总市值:30.49亿
流通股本:3.85亿   总股本:3.85亿

百花医药(600721)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入230,543,932.05157,357,180.8267,182,856.85388,319,392.98
营业总成本197,620,083.89129,665,410.3355,423,758.66310,478,518.94
其他经营收益
营业利润19,232,285.3716,584,474.837,290,434.5744,244,477.86
利润总额19,295,160.7816,717,956.197,263,417.8244,161,885.27
净利润16,819,736.6914,760,272.466,642,724.5640,687,937.25
每股收益
其他综合收益---40,319.46
综合收益总额16,819,736.6914,760,272.466,642,724.5640,728,256.71
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计545,020,864.73523,698,484.4556,291,882.1565,414,570.53
非流动资产:
非流动资产合计537,330,101.97541,435,606.46536,914,885.05532,155,763.19
资产总计1,082,350,966.71,065,134,090.861,093,206,767.151,097,570,333.72
流动负债:
流动负债合计229,674,174.63215,069,368.13235,460,885.49246,843,599.68
非流动负债:
非流动负债合计49,988,310.4449,403,385.449,265,128.5848,888,705.52
负债合计279,662,485.07264,472,753.53284,726,014.07295,732,305.2
所有者权益(或股东权益):
归属于母公司股东权益合计802,688,481.63800,661,337.33808,480,753.08801,838,028.52
股东权益合计802,688,481.63800,661,337.33808,480,753.08801,838,028.52
负债和股东权益合计1,082,350,966.71,065,134,090.861,093,206,767.151,097,570,333.72
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计216,576,454.72131,484,975.4161,008,490.84342,224,636.44
经营活动现金流出小计196,269,013.53132,497,014.770,645,085.33311,806,072.01
经营活动产生的现金流量净额20,307,441.19-1,012,039.29-9,636,594.4930,418,564.43
投资活动产生的现金流量:
投资活动现金流入小计1,041,022,187.97692,208,708.7243,259,643.79887,240,547.73
投资活动现金流出小计1,282,138,514.72905,836,697.69483,817,093.06906,445,051.66
投资活动产生的现金流量净额-241,116,326.75-213,627,988.99-240,557,449.27-19,204,503.93
筹资活动产生的现金流量:
筹资活动现金流入小计20,000,00020,000,00020,000,0002,564,700
筹资活动现金流出小计35,461,693.1835,461,693.1879,787.78-
筹资活动产生的现金流量净额-15,461,693.18-15,461,693.1819,920,212.222,564,700
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-236,270,578.74-230,101,721.46-230,273,831.5413,778,760.5
期末现金及现金等价物余额49,556,310.0155,725,167.2955,553,057.21285,826,888.75
补充资料:
现金及现金等价物的净增加额--230,101,721.46-13,778,760.5
TOP↑